Search bioRxiv⌕ Search

Biology subjects

Lopez-Cecetaite, G. A.

Publications and source records attributed to Lopez-Cecetaite, G. A..

2 recordsLinked to original sources

Developmental Immunotoxicity of Low-dose Inorganic Arsenic Reprograms Macrophages Inducing Tumor-promoting Phenotypes

In many regions around the world, including the United States, inorganic arsenic (iAs) contaminates groundwater used for drinking, food production, and irrigation. Although the World Health Organization has set a safety limit of 10 {micro}g/L for arsenic in drinking water, an estimated 200 million people worldwide are still exposed to arsenic concentrations above this threshold. Eliciting a broad range of adverse health effects, arsenic is a known carcinogen classified by the International Agency for Research on Cancer (IARC) and causes increased susceptibility to infectious diseases, highlighting its role as an immunotoxicant. The purpose of this study is to elucidate the effects of arsenic on the innate immune system, namely macrophages, using in vitro exposure models. Bone marrow-derived macrophages (BMDMs) were cultured from adult male and female C57/BL6 mice. These naive macrophages ("M0" BMDMs) were exposed in vitro to a non-cytotoxic dose of iAs (0.1 {micro}M sodium (meta)arsenite) during the 7 day period of macrophage differentiation and stimulated for 24 hrs with LPS and IFN{gamma} (to induce "M1" pro-inflammatory activation) or IL-4 and IL-13 (to induce "M2" anti-inflammatory activation). In a parallel chronic exposure model, RAW 264.7 (RAW) macrophages were cultured in vitro with iAs for 70 days. Culture supernatant analysis for nitric oxide and cytokine secretion revealed sex-dependent differences in immune response between exposure models, as well as between iAs-exposed and nonexposed macrophages, with and without stimulation. Additionally, iAs-exposed macrophages exhibited increased lipid droplet formation and altered lipidomic and metabolomic profiles, as determined by LC/MS. Flow cytometric analysis further revealed changes in macrophage polarization markers in a sex- and stimulation-dependent manner, with M2-related markers being upregulated in iAs-exposed conditions. Finally, to assess the effects of iAs on macrophages in the context of cancer, we demonstrated that iAs-exposed macrophages displayed increased migration toward cancer cell-conditioned media, and promoted cancer cell proliferation. These results suggest that dysregulated macrophage polarization due to iAs exposure could impact susceptibility to diseases. This research contributes to our understanding of the full spectrum of adverse health effects of iAs exposure and may aid in the development of therapeutics for iAs-induced diseases, including cancer.

immunology↗

Cell type specific CaMKII activation patterns revealed by CaMKAR, a bioactivity reporter deployable in living cells

An accurate and precise mechanism for measuring CaMKII activity in living cells is invaluable in the search for effective and targeted CaMKII-based therapeutics. Here, we employ our recently published CaMKII Activity Reporter (CaMKAR) biosensor in order to investigate the spatiotemporal dynamics of CaMKII activation in three different types of cells - cardiac myocytes, skeletal myocytes, and neurons. In doing so, we found a greater rate of CaMKII activation in skeletal muscle compared to cardiac muscle and also delineated CaMKARs ability to measure discrete CaMKII activation events in the presence of individual action potentials. By modifying the original CaMKAR sequence, we generated sensors that can be localized to subcellular compartments and thereby preferentially detect the activity of specific spatially-distributed CaMKII isoforms. Finally, we utilized the live-cell data to generate mathematical models of CaMKII activation kinetics, both as an integrated function across multiple calcium transients and as discrete on-off events following individual depolarizations. By furthering our understanding of CaMKII activity profiles across cell types and within subcellular compartments, we hope to support development of CaMKII inhibitors that are optimally precise and potent.

molecular biology↗